Xenopat

Developing xenograft models of cancer for drug development and personalized treatment selection

placeL'Hospitalet De Llobregat, Catalonia, Spain calendar_todayFounded 2014 groups4 employees language xenopat.com

Social engagement

Social engagement: 843 social following, 10 posts in the last 12 months — below the industry typical range.

Investor mix

2 investors on record.

Investor typeCountShare
Accelerator & incubator150%
Other / undisclosed150%

Recent activity

17 Dec 2025
Expansion
BeyondCatalonia25
Coming soon